Oxytocin Levels in Typically Developing Boys

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measuring basal levels of plasma oxytocin in individuals with typical development across childhood and adolescence using both extracted and unextracted EIA methods.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Inhaled Oxytocin and HPA Axis Reactivity

NCT03593473

Depression, Postpartum Anxiety Disorders Stress, Psychological

COMPLETED PHASE2

Oral Oxytocin Modulation of Responses to Emotional Stimuli

NCT04320706

Healthy

UNKNOWN NA

The Influence of Oxytocin on Pair-bonding and Emotion Regulation

NCT02501837

Healthy

COMPLETED EARLY_PHASE1

Effect of Oral Oxytocin on Women's Response to Emotional Stimuli

NCT05073939

Healthy

UNKNOWN NA

Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making

NCT01607970

Healthy Male Volunteers

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Measuring basal levels of plasma oxytocin in individuals with typical development across childhood and adolescence using both extracted and unextracted EIA methods. This study is necessary since there is great variability in reported plasma oxytocin in typically developing children from other studies as well as up to 1000 fold variability in such levels using different assay procedures. Further existing studies have not clearly described variation in levels with age. all samples will be taken in the afternoon.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Boys

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Age 3-6

This will include 10 typically developing boys age 3-6

No interventions assigned to this group

Age 7-12

This will include 10 typically developing boys age 7-12

No interventions assigned to this group

Age 13-17

This will include 10 typically developing boys age 13-17

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 3 and 17 years old, inclusive
* Consent of parent or guardian.

Exclusion Criteria

* Female gender
* Evidence of a mental health diagnosis
* Evidence of significant medical condition (ie: renal, cardiovascular or genetic disease)
* First degree family member with an ASD diagnosis

Minimum Eligible Age

3 Years

Maximum Eligible Age

17 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes